Monash University

ElectraLith develops direct lithium extraction and refining technology to enable efficient and sustainable lithium production. Its technology uses electricity to extract and refine lithium, with the aim of lowering costs for both brine and hard rock producers and enabling production from a broad range of feedstocks worldwide.

Inosi Therapeutics is a biotechnology company focused on developing innovative therapies to treat fibrosis, a condition characterized by tissue damage and scarring that can result in the loss of organ function. The company is pioneering a therapeutic approach that utilizes IRAP inhibitors, which can be tested independently or in conjunction with existing standard treatments. This unique mechanism of action aims to enhance the treatment of organ damage related to diabetes-induced kidney disease and cardiovascular disease. By addressing the underlying causes of fibrosis, Inosi Therapeutics aims to provide healthcare providers with effective solutions for managing chronic diseases associated with significant tissue damage.